113 related articles for article (PubMed ID: 8966008)
1. Minimal-change nephropathy induced by 5-aminosalicylic acid.
Zorzets Z; Bernheim J
Nephrol Dial Transplant; 1996 Jun; 11(6):1187-8. PubMed ID: 8966008
[No Abstract] [Full Text] [Related]
2. [Side effects of 5-aminosalicylic acid].
Marteau P; Cellier C
Gastroenterol Clin Biol; 1997; 21(5):377-86. PubMed ID: 9208013
[No Abstract] [Full Text] [Related]
3. [The treatment of inflammatory intestinal diseases with preparations of 5-aminosalicylic acid].
Frol'kis AV
Ter Arkh; 1996; 68(2):75-7. PubMed ID: 8771669
[No Abstract] [Full Text] [Related]
4. Folliculitis and mesalamine.
Lizasoain J; Rubio FA; Erdozain JC; Olveira A; Conde P
Am J Gastroenterol; 1996 Apr; 91(4):819-20. PubMed ID: 8677969
[No Abstract] [Full Text] [Related]
5. [Mesalazine].
Netzer P
Dtsch Med Wochenschr; 1996 Jan; 121(1-2):42. PubMed ID: 8565806
[No Abstract] [Full Text] [Related]
6. Minimal change nephrotic syndrome associated with non steroidal antiinflammatory drugs. A need for careful evaluation.
Labeeuw M; Cabanne JF; Dubot P
Clin Nephrol; 1987 Mar; 27(3):162. PubMed ID: 3568464
[No Abstract] [Full Text] [Related]
7. Cutaneous hypersensitivity reaction to mesalazine.
Aparicio J; Carnicer F; Girona E; Gmez A
Am J Gastroenterol; 1996 Mar; 91(3):620-1. PubMed ID: 8633534
[No Abstract] [Full Text] [Related]
8. [Thrombopenia during 5-ASA treatment (mesalazine and olsalazine)].
Benoit R; Grobost O; Bichoffe A; Dol L
Gastroenterol Clin Biol; 1999 Mar; 23(3):410-1. PubMed ID: 10384350
[No Abstract] [Full Text] [Related]
9. [Fever and hypotension following oral administration of mesalazine].
Galofré N; Cirera I; Supervía A; Peña MJ
Med Clin (Barc); 1995 Mar; 104(9):358. PubMed ID: 7731308
[No Abstract] [Full Text] [Related]
10. [5-Aminosalicylic acid in treatment of non-specific enteritis].
Adrych K; Zaucha JM; Kryszewski A
Wiad Lek; 1993 Nov; 46(21-22):833-6. PubMed ID: 7817574
[No Abstract] [Full Text] [Related]
11. Nephrotic syndrome due to isolated minimal change glomerular disease in a patient taking pirprofen.
Hannedouche T; Fournier JF; Moore N; Godin M; Fillastre JP
Clin Nephrol; 1986 Jun; 25(6):314. PubMed ID: 3488152
[No Abstract] [Full Text] [Related]
12. Comparative pharmacokinetics of equimolar doses of 5-aminosalicylate administered as oral mesalamine (Asacol) and balsalazide: a randomized, single-dose, crossover study in healthy volunteers.
Sandborn WJ; Hanauer SB; Buch A
Aliment Pharmacol Ther; 2004 May; 19(10):1089-98. PubMed ID: 15142198
[TBL] [Abstract][Full Text] [Related]
13. Quiz page. Acute interstitial nephritis and minimal change disease lesion, caused by NSAID injury.
Fogo AB
Am J Kidney Dis; 2003 Aug; 42(2):A41, E1. PubMed ID: 12900841
[No Abstract] [Full Text] [Related]
14. Minimal change disease and acute tubular necrosis caused by diclofenac.
Galesic K; Ljubanovic D; Bulimbasic S; Racic I
Nephrology (Carlton); 2008 Feb; 13(1):87-8. PubMed ID: 18199110
[No Abstract] [Full Text] [Related]
15. [Development toward segmental and focal hyalinosis of a nephrotic syndrome with minimal glomerular lesions in a patient treated with sulindac].
Pagniez D; Gosset D; Hardouin P; Noël C; Delvallez L; Dequiedt P
Nephrologie; 1988; 9(2):90-1. PubMed ID: 2459625
[No Abstract] [Full Text] [Related]
16. Mesalamine-induced lung disease.
Lázaro MT; García-Tejero MT; Díaz-Lobato S
Arch Intern Med; 1997 Feb; 157(4):462. PubMed ID: 9046901
[No Abstract] [Full Text] [Related]
17. Interstitial pneumonitis due to mesalamine.
Pascual-Lledó JF; Calvo-Bonachera J; Carrasco-Miras F; Sanchez-Martínez H
Ann Pharmacother; 1997 Apr; 31(4):499. PubMed ID: 9101017
[No Abstract] [Full Text] [Related]
18. Adverse pulmonary effects of mesalamine.
Muzzi A; Ciani F; Bianchini D; Festini G; Volpe C
Chest; 1995 Oct; 108(4):1181. PubMed ID: 7555145
[No Abstract] [Full Text] [Related]
19. Mesalazine-associated interstitial nephritis.
Mani V
Nephrol Dial Transplant; 1997 Mar; 12(3):622-3. PubMed ID: 9075162
[No Abstract] [Full Text] [Related]
20. Minimal-change disease and interstitial nephritis secondary to non-steroidal anti-inflammatory drugs (naproxen).
Baccouche K; Alaya Z; Azzabi A; Ben Abdelkarim S; Belghali S; El Amri N; Zeglaoui H; Slim R; Bouajina E
Therapie; 2016 Oct; 71(5):515-517. PubMed ID: 27203163
[No Abstract] [Full Text] [Related]
[Next] [New Search]
